日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Dual roles of BK Polyomavirus in promoting urothelial carcinoma progression via regulating CLDN1

BK多瘤病毒通过调控CLDN1在促进尿路上皮癌进展中发挥双重作用

Xu, Cuidi; Chen, Siyue; Chen, Juntao; Wang, Jina; Niu, Xinhao; Rong, Ruiming; Zhu, Tongyu; Zeng, Yigang

Impact of concomitant medications on efficacy of CLDN18.2-specific CAR-T cell therapy in advanced gastric cancer

伴随用药对CLDN18.2特异性CAR-T细胞疗法治疗晚期胃癌疗效的影响

Li, Jiarui; Liu, Lian; Tao, Min; Han, Zihan; Ma, Mingyang; Jiang, Lei; Liu, Chang; Liu, Dan; Zhang, Panpan; Zhang, Miao; Xue, Ran; Gong, Jifang; Zhang, Xiaotian; Shen, Lin; Qi, Changsong

A Bioinformatics and Wet-Lab-Based Pipeline Identifies CLDN10 and GJB2 as Epigenetically Silenced Tumor Suppressor Genes in Cutaneous Melanoma

基于生物信息学和湿实验室的流程鉴定出CLDN10和GJB2是皮肤黑色素瘤中表观遗传沉默的抑癌基因

Arroyo Villora, Sarah; Baumann, Veit Xaver; Zhao, Yufen; Philipp, Niklas; Dammann, Reinhard H; Sigges, Cornelia; Richter, Antje Maria

Subgroup Modelling and Use of External Evidence in Precision Oncology Appraisals: An External Assessment Group Perspective on the NICE Single Technology Appraisal of Zolbetuximab for Untreated CLDN18.2-Positive HER2-Negative Unresectable Advanced Gastric or Gastro-oesophageal Junction Adenocarcinoma

亚组建模和外部证据在精准肿瘤学评估中的应用:外部评估小组对NICE单项技术评估佐贝妥昔单抗治疗未经治疗的CLDN18.2阳性HER2阴性不可切除的晚期胃癌或胃食管交界处腺癌的视角

Scholte, Mirre; Fernández Coves, Andrea; Yang, Huiqin; Armstrong, Nigel; McDermott, Kevin; Tian, Xiaoyu; Stirk, Lisa; Wolff, Robert; Joore, Manuela A; Grimm, Sabine E

Multi-omics analysis identifies CLDN10 as a B-cell-associated prognostic biomarker in HPV-negative head and neck squamous cell carcinoma

多组学分析发现 CLDN10 是 HPV 阴性头颈部鳞状细胞癌中与 B 细胞相关的预后生物标志物

Dang, Qihua; He, Yayun; Zhao, Runan; Chen, Hongyuan; Yin, Lijuan; Lu, Yanhua; Shi, Xiaocheng; Li, Yiming; Chen, Yanhua; Gao, Yisha; He, Miaoxia

Familial hypomagnesemia with hypercalciuria and nephrocalcinosis caused by CLDN16/CLDN19 mutations in four Chinese families

中国四家族中由CLDN16/CLDN19基因突变引起的家族性低镁血症伴高钙尿症和肾钙质沉着症

Wang, Chun; Ding, Juanjuan; Yang, Huihui; Huang, Lin; Wang, Xiaowen

CLDN18.2 in Gastric Cancer: Current Therapeutic Landscape and Future Perspectives

CLDN18.2在胃癌中的作用:当前治疗现状及未来展望

Zhang, Fei; Okazaki, Ukyo; Nakayama, Izuma; Shitara, Kohei

FAT2 inhibits breast cancer cell migration, invasion, and epithelial-mesenchymal transition through transcriptional upregulation of CLDN19

FAT2通过转录上调CLDN19抑制乳腺癌细胞的迁移、侵袭和上皮-间质转化。

Xie, Gangyin; Lu, Dengwei; Li, Ziwei; Xu, Tao

Immunohistochemical Analysis of Potential Therapeutic Targets PRAME, FOLR1, and CLDN18.2 in Salivary Gland Carcinomas

唾液腺癌中潜在治疗靶点PRAME、FOLR1和CLDN18.2的免疫组织化学分析

Brust, Lukas A; Kühn, Jan Philipp; Körner, Sandrina; Knebel, Moritz; Braun, Felix L; Zeidan, Philippe; Wemmert, Silke; Schick, Bernhard; Smola, Sigrun; Wagner, Mathias; Ertz, Martin; Linxweiler, Maximilian

Molecular dynamics analyses of CLDN15 pore size and charge selectivity

CLDN15孔径和电荷选择性的分子动力学分析

McGuinness, Sarah; Li, Pan; Li, Ye; Fuladi, Shadi; Konar, Sukanya; Sajjadi, Samaneh; Sidahmed, Mohammed; Li, Yueying; Shen, Le; Khalili-Araghi, Fatemeh; Weber, Christopher R